Currently, there are a total of ten FDA-approved indications for hGH therapy [5]: Growth hormone deficiency in children and adults (GHD) Growth failure due to chronic renal insufficiency Muscle wasting due to AIDS Noonan syndrome Prader-Willi syndrome Short bowel syndrome (SBS) Short stature homeobox (SHOX)-containing gene deficiency Small-for-gestational-age infants Turner syndrome Recombinant hGH therapy can effectively and dose-dependently increase serum GH levels, hence its use in managing the symptoms of GHD in children and adults
doi:10.4103/aja.aja_87_20 Dupont C, Faure C, Daoud F, Gautier B, Czernichow S, Lvy R
validated cold chain containers with digital logging are required for international transport exceeding 48 hours
B.FavalliG.BlumbergerD
A: The product undergoes stringent quality testing, complies with pharmaceutical standards, and includes proper certifications to ensure top-grade purity and safety.
doi: 10.1016/S0140-6736(18)32261-X 229 GarveyWTFriasJPJastreboffAMle RouxCWSattarNAizenbergDet al